The function of miRNAs in hepatocarcinogenesis induced by hepatitis B virus X protein (Review)
- Authors:
- Ziyao Wang
- Zhongjun Wu
- Ping Huang
-
Affiliations: National Key Clinical Department, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing 400000, P.R. China - Published online on: June 13, 2017 https://doi.org/10.3892/or.2017.5716
- Pages: 652-664
This article is mentioned in:
Abstract
 |
 |
 |
|
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
McGlynn KA, Petrick JL and London WT: Global epidemiology of hepatocellular carcinoma: An emphasis on demographic and regional variability. Clin Liver Dis. 19:223–238. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Center MM and Jemal A: International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 20:2362–2368. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Parkin DM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 118:3030–3044. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Seeger C and Mason WS: Hepatitis B virus biology. Microbiol Mol Biol Rev. 64:51–68. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Tang H, Oishi N, Kaneko S and Murakami S: Molecular functions and biological roles of hepatitis B virus × protein. Cancer Sci. 97:977–983. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Xu C, Zhou W, Wang Y and Qiao L: Hepatitis B virus-induced hepatocellular carcinoma. Cancer Lett. 345:216–222. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kremsdorf D, Soussan P, Paterlini-Brechot P and Brechot C: Hepatitis B virus-related hepatocellular carcinoma: Paradigms for viral-related human carcinogenesis. Oncogene. 25:3823–3833. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Wu SY, Lan SH and Liu HS: Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol. 22:176–187. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J and Ma L: MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev. 31:653–662. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
de Gómez Cedrón M and de Ramírez Molina A: Microtargeting cancer metabolism: Opening new therapeutic windows based on lipid metabolism. J Lipid Res. 57:193–206. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Peschansky VJ and Wahlestedt C: Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics. 9:3–12. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Callegari E, Elamin BK, Sabbioni S, Gramantieri L and Negrini M: Role of microRNAs in hepatocellular carcinoma: A clinical perspective. Onco Targets Ther. 6:1167–1178. 2013.PubMed/NCBI | |
|
Shan X, Ren M, Chen K, Huang A and Tang H: Regulation of the microRNA processor DGCR8 by hepatitis B virus proteins via the transcription factor YY1. Arch Virol. 160:795–803. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Rodriguez A, Griffiths-Jones S, Ashurst JL and Bradley A: Identification of mammalian microRNA host genes and transcription units. Genome Res. 14:(10A). 1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Ruby JG, Jan CH and Bartel DP: Intronic microRNA precursors that bypass Drosha processing. Nature. 448:83–86. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Okamura K, Hagen JW, Duan H, Tyler DM and Lai EC: The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell. 130:89–100. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Jiang L, Ji X, Yang B, Zhang Y and Fu XD: Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes. J Biol Chem. 288:18484–18493. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li C, Wang Y, Wang S, Wu B, Hao J, Fan H, Ju Y, Ding Y, Chen L, Chu X, et al: Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J Virol. 87:2193–2205. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Cazalla D, Yario T, Steitz JA and Steitz J: Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science. 328:1563–1566. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Feitelson MA and Lee J: Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett. 252:157–170. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Liu S, Hu T, Liu S, He Y and Sun S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 50:490–499. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Li JF, Dai XP, Zhang W, Sun SH, Zeng Y, Zhao GY, Kou ZH, Guo Y, Yu H, Du LY, et al: Upregulation of microRNA-146a by hepatitis B virus X protein contributes to hepatitis development by downregulating complement factor H. MBio. 6:e02459–14. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, Zhu Z, Jiao H, Lin J, Jiang K, et al: Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest. 123:630–645. 2013.PubMed/NCBI | |
|
Peng F, Xiao X, Jiang Y, Luo K, Tian Y, Peng M, Zhang M, Xu Y and Gong G: HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122. PLoS One. 9:e929982014. View Article : Google Scholar : PubMed/NCBI | |
|
Hu XM, Yan XH, Hu YW, Huang JL, Cao SW, Ren TY, Tang YT, Lin L, Zheng L and Wang Q: MicroRNA-548p suppresses hepatitis B virus X protein associated hepatocellular carcinoma by downregulating oncoprotein HBXIP. Hepatol Res. 46:804–815. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu FY, Zhou SJ, Deng YL, Zhang ZY, Zhang EL, Wu ZB, Huang ZY and Chen XP: MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway. Cell Death Dis. 6:e16702015. View Article : Google Scholar : PubMed/NCBI | |
|
Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J and Song E: Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer. 105:146–153. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wu G, Huang P, Ju X, Li Z and Wang Y: Lin28B over-expression mediates the repression of let-7 by hepatitis B virus X protein in hepatoma cells. Int J Clin Exp Med. 8:15108–15116. 2015.PubMed/NCBI | |
|
Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao Y, Li Y, Zeng T, Hu J, Zhang L, et al: HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene. 32:3296–3305. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang W, Lu Z, Kong G, Gao Y, Wang T, Wang Q, Cai N, Wang H, Liu F, Ye L, et al: Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP. Mol Cancer. 13:1282014. View Article : Google Scholar : PubMed/NCBI | |
|
Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R and Wu Z: Epigenetic repression of miR-132 expression by the hepatitis B virus × protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal. 25:1037–1043. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan K, Lian Z, Sun B, Clayton MM, Ng IO and Feitelson MA: Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One. 7:e353312012. View Article : Google Scholar : PubMed/NCBI | |
|
Chen YJ, Chien PH, Chen WS, Chien YF, Hsu YY, Wang LY, Chen JY, Lin CW, Huang TC, Yu YL, et al: Hepatitis B Virus-encoded X Protein downregulates EGFR expression via inducing MicroRNA-7 in hepatocellular carcinoma cells. Evid Based Complement Alternat Med. 2013:6823802013.PubMed/NCBI | |
|
Chen WS, Yen CJ, Chen YJ, Chen JY, Wang LY, Chiu SJ, Shih WL, Ho CY, Wei TT, Pan HL, et al: miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin. Oncotarget. 6:25962–25974. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB and Chen Y: Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Eur J Cancer. 50:2560–2569. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Damania P, Sen B, Dar SB, Kumar S, Kumari A, Gupta E, Sarin SK and Venugopal SK: Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). PLoS One. 9:e917452014. View Article : Google Scholar : PubMed/NCBI | |
|
Dai X, Zhang W, Zhang H, Sun S, Yu H, Guo Y, Kou Z, Zhao G, Du L, Jiang S, et al: Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α. Nucleic Acids Res. 42:6578–6590. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC, Wu CY and Yu YL: Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. Int J Cancer. 134:1638–1647. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kong G, Zhang J, Zhang S, Shan C, Ye L and Zhang X: Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One. 6:e195182011. View Article : Google Scholar : PubMed/NCBI | |
|
Mosca N, Castiello F, Coppola N, Trotta MC, Sagnelli C, Pisaturo M, Sagnelli E, Russo A and Potenza N: Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection. Biochem Biophys Res Commun. 449:141–145. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X and Wu Z: miR-101 is down-regulated by the hepatitis B virus × protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell Signal. 25:439–446. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liang HW, Wang N, Wang Y, Wang F, Fu Z, Yan X, Zhu H, Diao W, Ding Y, Chen X, et al: Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J Hepatol. 64:278–291. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao J, Wang W, Huang Y, Wu J, Chen M, Cui P, Zhang W and Zhang Y: HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes. DNA Cell Biol. 33:715–722. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gao F, Sun X, Wang L, Tang S and Yan C: Downregulation of MicroRNA-145 caused by hepatitis B virus X protein promotes expression of CUL5 and contributes to pathogenesis of hepatitis B Virus-associated hepatocellular carcinoma. Cell Physiol Biochem. 37:1547–1559. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Arzumanyan A, Friedman T, Ng IO, Clayton MM, Lian Z and Feitelson MA: Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res. 71:3701–3708. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Huang J, Wang Y, Guo Y and Sun S: Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Liu F, You X, Chi X, Wang T, Ye L, Niu J and Zhang X: Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT. Biochem Biophys Res Commun. 444:128–134. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yip WK, Cheng AS, Zhu R, Lung RW, Tsang DP, Lau SS, Chen Y, Sung JG, Lai PB, Ng EK, et al: Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development. PLoS One. 6:e228882011. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JJ, Tang YS, Huang SF, Ai JG, Wang HX and Zhang LP: HBx protein-induced upregulation of microRNA-221 promotes aberrant proliferation in HBV-related hepatocellular carcinoma by targeting estrogen receptor-α. Oncol Rep. 33:792–798. 2015.PubMed/NCBI | |
|
Zhang T, Zhang J, Cui M, Liu F, You X, Du Y, Gao Y, Zhang S, Lu Z, Ye L, et al: Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Neoplasia. 15:1282–1291. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Cui M, Xiao Z, Sun B, Wang Y, Zheng M, Ye L and Zhang X: Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4. Biochem Biophys Res Commun. 445:651–655. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cui M, Wang Y, Sun B, Xiao Z, Ye L and Zhang X: MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. Biochem Biophys Res Commun. 444:270–275. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lan SH, Wu SY, Zuchini R, Lin XZ, Su IJ, Tsai TF, Lin YJ, Wu CT and Liu HS: Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224. Hepatology. 59:505–517. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A and Tang H: Upregulated in hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Oncotarget. 6:38093–38106. 2015.PubMed/NCBI | |
|
Arzumanyan A, Friedman T, Kotei E, Ng IO, Lian Z and Feitelson MA: Epigenetic repression of E-cadherin expression by hepatitis B virus × antigen in liver cancer. Oncogene. 31:563–572. 2012.PubMed/NCBI | |
|
Zhao Q, Li T, Qi J, Liu J and Qin C: The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression. PLoS One. 9:e1097822014. View Article : Google Scholar : PubMed/NCBI | |
|
You X, Liu F, Zhang T, Li Y, Ye L and Zhang X: Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. Carcinogenesis. 34:1644–1652. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bui-Nguyen TM, Pakala SB, Sirigiri DR, Martin E, Murad F and Kumar R and Kumar R and Kumar R: Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J Biol Chem. 291:11982016. View Article : Google Scholar : | |
|
Yang L, Ma Z, Wang D, Zhao W, Chen L and Wang G: MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma. Cancer Biol Ther. 9:803–808. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kew MC: Hepatitis B virus × protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol. 26:(Suppl 1). 144–152. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lizzano RA, Yang B, Clippinger AJ and Bouchard MJ: The C-terminal region of the hepatitis B virus X protein is essential for its stability and function. Virus Res. 155:231–239. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Schuster R, Gerlich WH and Schaefer S: Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene. 19:1173–1180. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C and Kremsdorf D: Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res. 61:7803–7810. 2001.PubMed/NCBI | |
|
Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D and Bréchot C: Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene. 18:4848–4859. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Ma NF, Lau SH, Hu L, Xie D, Wu J, Yang J, Wang Y, Wu MC, Fung J, Bai X, et al: COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res. 14:5061–5068. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sze KM, Chu GK, Lee JM and Ng IO: C-terminal truncated hepatitis B virus × protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology. 57:131–139. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Shan CL, Li N, Zhang X, Zhang XZ, Xu FQ, Zhang S, Qiu LY, Ye LH and Zhang XD: Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation. Acta Pharmacol Sin. 29:473–480. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
McDaniel K, Herrera L, Zhou T, Francis H, Han Y, Levine P, Lin E, Glaser S, Alpini G and Meng F: The functional role of microRNAs in alcoholic liver injury. J Cell Mol Med. 18:197–207. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ding D, Lou X, Hua D, Yu W, Li L, Wang J, Gao F, Zhao N, Ren G, Li L, et al: Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet. 8:e10030652012. View Article : Google Scholar : PubMed/NCBI | |
|
Lau CC, Sun T, Ching AK, He M, Li JW, Wong AM, Co NN, Chan AW, Li PS, Lung RW, et al: Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell. 25:335–349. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S and Ørum H: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 327:198–201. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, Barton DJ and Lemon SM: Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci USA. 109:941–946. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bandiera S, Pfeffer S, Baumert TF and Zeisel MB: miR-122 - a key factor and therapeutic target in liver disease. J Hepatol. 62:448–457. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Luna JM, Scheel TK, Danino T, Shaw KS, Mele A, Fak JJ, Nishiuchi E, Takacs CN, Catanese MT, de Jong YP, et al: Hepatitis C virus RNA functionally sequesters miR-122. Cell. 160:1099–1110. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Romito A and Rougeulle C: Origin and evolution of the long non-coding genes in the X-inactivation center. Biochimie. 93:1935–1942. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Astronomo RD and Burton DR: Carbohydrate vaccines: Developing sweet solutions to sticky situations? Nat Rev Drug Discov. 9:308–324. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kim YC, Song KS, Yoon G, Nam MJ and Ryu WS: Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis. Oncogene. 20:16–23. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang W, Kong G, Zhang J, Wang T, Ye L and Zhang X: MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1. PLoS One. 7:e314502012. View Article : Google Scholar : PubMed/NCBI | |
|
Melegari M, Scaglioni PP and Wands JR: Cloning and characterization of a novel hepatitis B virus × binding protein that inhibits viral replication. J Virol. 72:1737–1743. 1998.PubMed/NCBI | |
|
Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM and Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 317:121–124. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D and Cheng JQ: MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem. 283:31079–31086. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Pike MC and Spicer DV: Hormonal contraception and chemoprevention of female cancers. Endocr Relat Cancer. 7:73–83. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Dutertre M and Smith CL: Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther. 295:431–437. 2000.PubMed/NCBI | |
|
Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, et al: EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res. 70:8822–8831. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lubbers J, Lewis S, Harper E, Hledin MP, Marquez GA, Johnson AE, Graves DR and Burnatowska-Hledin MA: Resveratrol enhances anti-proliferative effect of VACM-1/cul5 in T47D cancer cells. Cell Biol Toxicol. 27:95–105. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Frisch SM and Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 124:619–626. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Taddei ML, Giannoni E, Fiaschi T and Chiarugi P: Anoikis: An emerging hallmark in health and diseases. J Pathol. 226:380–393. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 263:526–529. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Bailey CM, Khalkhali-Ellis Z, Seftor EA and Hendrix MJ: Biological functions of maspin. J Cell Physiol. 209:617–624. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K and Matsuhashi S: Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene. 25:6101–6112. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka Y, Kanai F, Ichimura T, Tateishi K, Asaoka Y, Guleng B, Jazag A, Ohta M, Imamura J, Ikenoue T, et al: The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene. 25:633–642. 2006.PubMed/NCBI | |
|
Talotta F, Cimmino A, Matarazzo MR, Casalino L, De Vita G, DEsposito M, Di Lauro R and Verde P: An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene. 28:73–84. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL and Colburn NH: A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene. 20:669–676. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Guo Y, Chen Y, Ito H, Watanabe A, Ge X, Kodama T and Aburatani H: Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene. 384:51–61. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P and Buendia MA: p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene. 17:2115–2123. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Ng SA and Lee C: Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol. 46:974–990. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SY, Kim JC, Kim JK, Kim HJ, Lee HM, Choi MS, Maeng PJ and Ahn JK: Hepatitis B virus X protein enhances NFkappaB activity through cooperating with VBP1. BMB Rep. 41:158–163. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Dasari VR, Kaur K, Velpula KK, Gujrati M, Fassett D, Klopfenstein JD, Dinh DH and Rao JS: Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway. PLoS One. 5:e103502010. View Article : Google Scholar : PubMed/NCBI | |
|
van Roy F and Berx G: The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R and Hendrix MJ: maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res. 58:5681–5685. 1998.PubMed/NCBI | |
|
Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, et al: MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA. 104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wang SC, Lin XL, Li J, Zhang TT, Wang HY, Shi JW, Yang S, Zhao WT, Xie RY, Wei F, et al: MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. PLoS One. 9:e1013302014. View Article : Google Scholar : PubMed/NCBI | |
|
He C and Klionsky DJ: Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tian Y, Sir D, Kuo CF, Ann DK and Ou JH: Autophagy required for hepatitis B virus replication in transgenic mice. J Virol. 85:13453–13456. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tang H, Da L, Mao Y, Li Y, Li D, Xu Z, Li F, Wang Y, Tiollais P, Li T, et al: Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression. Hepatology. 49:60–71. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Bhogal RH, Weston CJ, Curbishley SM, Adams DH and Afford SC: Autophagy: A cyto-protective mechanism which prevents primary human hepatocyte apoptosis during oxidative stress. Autophagy. 8:545–558. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar S, Gupta P, Khanal S, Shahi A, Kumar P, Sarin SK and Venugopal SK: Overexpression of microRNA-30a inhibits hepatitis B virus X protein-induced autophagosome formation in hepatic cells. FEBS J. 282:1152–1163. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Huo TI, Lee SD and Wu JC: Is diabetes a risk factor for hepatocellular carcinoma? Gastroenterology. 127:360–361; author reply 361–362. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Hsieh JL, Wu CL, Lee CH and Shiau AL: Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function. Clin Cancer Res. 9:338–345. 2003.PubMed/NCBI | |
|
Su F, Theodosis CN and Schneider RJ: Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol. 75:215–225. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Majano P, Lara-Pezzi E, López-Cabrera M, Apolinario A, Moreno-Otero R and García-Monzón C: Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: Evidence that cytoplasmic location of X protein is essential for gene transactivation. Hepatology. 34:1218–1224. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Jahani-Asl A and Bonni A: iNOS: A potential therapeutic target for malignant glioma. Curr Mol Med. 13:1241–1249. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chisari FV, Isogawa M and Wieland SF: Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 58:258–266. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Fattovich G, Stroffolini T, Zagni I and Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology. 127:(Suppl 1). S35–S50. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Huang R and Rofstad EK: Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget. 8:35351–35367. 2017.PubMed/NCBI | |
|
Schmelzer E, Wauthier E and Reid LM: The phenotypes of pluripotent human hepatic progenitors. Stem Cells. 24:1852–1858. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Munz M, Baeuerle PA and Gires O: The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 69:5627–5629. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ji J, Zheng X, Forgues M, Yamashita T, Wauthier EL, Reid LM, Wen X, Song Y, Wei JS, Khan J, et al: Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma. Hepatology. 62:829–840. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang F and Du G: Dysregulated lipid metabolism in cancer. World J Biol Chem. 3:167–174. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, Van Veldhoven PP, Waltregny D, Daniëls VW, Machiels J, et al: De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res. 70:8117–8126. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chia WJ and Tang BL: Emerging roles for Rab family GTPases in human cancer. Biochim Biophys Acta. 1795:110–116. 2009.PubMed/NCBI | |
|
Pulido MR, Diaz-Ruiz A, Jiménez-Gómez Y, Garcia-Navarro S, Gracia-Navarro F, Tinahones F, López-Miranda J, Frühbeck G, Vázquez-Martínez R and Malagón MM: Rab18 dynamics in adipocytes in relation to lipogenesis, lipolysis and obesity. PLoS One. 6:e229312011. View Article : Google Scholar : PubMed/NCBI | |
|
Morales A, Mari M, Garcia-Ruiz C, Colell A and Fernandez-Checa JC: Hepatocarcinogenesis and ceramide/cholesterol metabolism. Anticancer Agents Med Chem. 12:364–375. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Parkes HA, Preston E, Wilks D, Ballesteros M, Carpenter L, Wood L, Kraegen EW, Furler SM and Cooney GJ: Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo. Am J Physiol Endocrinol Metab. 291:E737–E744. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Li LO, Ellis JM, Paich HA, Wang S, Gong N, Altshuller G, Thresher RJ, Koves TR, Watkins SM, Muoio DM, et al: Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition. J Biol Chem. 284:27816–27826. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Duarte A, Poderoso C, Cooke M, Soria G, Maciel Cornejo F, Gottifredi V and Podestá EJ: Mitochondrial fusion is essential for steroid biosynthesis. PLoS One. 7:e458292012. View Article : Google Scholar : PubMed/NCBI | |
|
Wen J and Friedman JR: miR-122 regulates hepatic lipid metabolism and tumor suppression. J Clin Invest. 122:2773–2776. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
DAmbrogio A, Gu W, Udagawa T, Mello CC and Richter JD: Specific miRNA stabilization by Gld2-catalyzed monoadenylation. Cell Rep. 2:1537–1545. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Liu WH, Yeh SH and Chen PJ: Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochim Biophys Acta. 1809:678–685. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Xu Z, Zheng Y, Johnson DL and Ou JH: Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins. J Virol. 76:5875–5881. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Piriyapongsa J and Jordan IK: A family of human microRNA genes from miniature inverted-repeat transposable elements. PLoS One. 2:e2032007. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan Z, Sun X, Liu H and Xie J: MicroRNA genes derived from repetitive elements and expanded by segmental duplication events in mammalian genomes. PLoS One. 6:e176662011. View Article : Google Scholar : PubMed/NCBI |
